Pursuant to Regulation 30(6) and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the presentation to be shared at the Investors Conference Call scheduled to be held today i.e. November 15, 2022.
Please find enclosed a copy of the Investor Presentation dated 14th November, 2022. The contents of the Investor Presentation give full details. Kindly take the above information on your records and oblige.
Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed herewith Investor Presentation on Q2FY23 Unaudited Financial Results. The same will also be available on the website of the Company at www.blackbox.com. This is for your information, record and necessary dissemination to all the stakeholders.
With reference to the captioned subject, please find enclosed the Investor Presentation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'). The above information will also be available on the website of the Company at www.biocon.com.
Pursuant to Regulation 30 read with Part A of Schedule III of SEBl (Listing Obligations and Disclosure Requirements) Regulation 2015, we are enclosing herewith the Corporate Presentation on Q2 & H1 FY23 of the Company. The copy of the said presentation is also being hosted on the website of the company. Kindly acknowledge the same.
Dear Sir Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed Investor Presentation on Operational and Financial Performance of the Company for the Quarter ended on September 30, 2022. The Investor Presentation is also being hosted on the website of the Company viz., https://www.cosmofirst.com/investors/investors-presentation.
In furtherance to our Letter No. CO/SEC/4(7)/2022-23/ BSE & NSE Filing/73 dated 8th November, 2022 regarding intimation of Conference Call scheduled to be held today, the 15th November, 2022 at 1600 hours, please find attached herewith copy of the presentation which would be discussed during the meeting.